Patent details

Basic Information

Publication number:

EP1079803

PCT Application Number:

PCT/CA/1999/000376

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP999177157

PCT Publication Number:

WO/1999/055353

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PROTEIN FORMULATIONS

French Title of Invention:

FORMULATIONS PROTEINIQUES

German Title of Invention:

PROTEINHALTIGE ARZNEIMITTEL

SPC Number:

91281

Dates

Filing date:

26/04/1999

Grant date:

18/08/2004

EP Publication Date:

18/08/2004

PCT Publication Date:

04/11/1999

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/03/2001

EP B1 Publication Date:

18/08/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

26/04/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/07/2017

 

 

Name:

Shire-NPS Pharmaceuticals, Inc.

Address:

300 Shire Way, Lexington, MA 02421, United States (US)

History of Owners

From:

16/02/2017

To:

20/07/2017

Name:

Shire-NPS Pharmaceuticals, Inc.

Address:

HILLS DRIVE, 3RD FLOOR 550, BEDMINSTER, NJ 07921, United States (US)

From:

24/09/2008

To:

16/02/2017

Name:

NPS PHARMACEUTICALS, INC.

Address:

HILLS DRIVE, 3RD FLOOR 550, BEDMINSTER, NJ 07921, United States (US)

From:

26/04/1999

To:

23/09/2008

Name:

NPS ALLELIX CORP. C/0 BLAKE, CASSELS&GRAYDON LLP

Address:

BAY STREET, SUITE 2800, COMMERCE COURT WEST 199, TORONTO, ON M5L 1A9, Canada (CA)

Inventor

1

Name:

BRULLS Mikael

Address:

Sweden (SE)

2

Name:

BILLGER Martin

Address:

Sweden (SE)

Priority

Priority Number:

9801495

Priority Date:

28/04/1998

Priority Country:

Sweden (SE)

Classification

Main IPC Class:

A61K 9/08;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2017/01

Publication date:

16/03/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2017/04

Publication date:

04/08/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20170000030A

Date Registered:

16/02/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

MARKS & CLERK (Luxembourg) LLP

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Shire-NPS Pharmaceuticals, Inc.

Address:

HILLS DRIVE, 3RD FLOOR 550, BEDMINSTER, NJ 07921, United States (US)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20170000253A

Date Registered:

20/07/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

MARKS & CLERK LLP

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Shire-NPS Pharmaceuticals, Inc.

Address:

300 Shire Way, Lexington, MA 02421, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

25/04/2018

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages
16/02/2017	Request For Change	3
20/07/2017	Request For Change	1